Case 01 • McKinsey (Round 1)
Healthcare & MedTech
TAM: €2.34B • Market Entry
AlphaHealth — EU Robotic Surgery Market Entry
A $4B US surgical robotics manufacturer with 72% domestic market share is evaluating an 18-month expansion into the European Union. Candidates must isolate upfront capital sales (€1.8M/console) from recurring consumable instrument margins (€2,200/procedure) while navigating 14-month EU CE Mark regulatory delays.
Opus Focus: MECE Issue Tree & Hospital Unit Economics
Simulate in Cockpit →
Case 02 • BCG (Round 1)
B2B Enterprise Software
EBITDA Turnaround (+18% to -6%)
NordicSaaS — B2B Software Profit Leak
A Nordic cloud ERP provider grows revenue by 35% to $120M, but EBITDA margins plummet from +18% to -6%. Candidates must detect that high cohort churn in micro-SMEs (CAC/LTV < 1) is cannibalizing profitable mid-market expansion (124% Net Retention Rate).
Opus Focus: Cohort Churn & Rule of 40 Analysis
Simulate in Cockpit →
Case 03 • Bain (Round 2)
Private Equity / Automotive
LBO 7.0x EV/EBITDA • Target IRR 22%
Apex Capital — Buyout of AutoParts Inc.
Commercial due diligence for a $1.4B acquisition of an internal combustion powertrain supplier. Candidates must evaluate EV transition risks, OEM volume declines (-9%/yr), and high-margin aftermarket stability (24% EBITDA) to determine whether to recommend against closing the deal.
Opus Focus: Cash Flow Sensitivities & Exit Multiple De-rating
Simulate in Cockpit →
Case 04 • McKinsey (Round 2)
Aviation & Travel
+$80M Bottom-line Yield
SkyWings Airline — Dynamic Pricing & Ancillary Yield
A full-service carrier operating 60 aircraft transports 13.2M passengers at an 84% load factor. Candidates must structure dynamic pricing models to double per-passenger ancillary revenue from $6 to $12, adding ~$80M straight to net earnings.
Opus Focus: Quantitative Gating & Price Elasticity Curves
Simulate in Cockpit →
Cases 05 to 10 Available in Full Suite
Includes EcoWatt Grid Bottleneck (BCG), Maison Luxe DTC Strategy (Bain), FinPay SuperApp Banking (McKinsey Partner Round), BioGen Rare Disease QALY Pricing (BCG), FastLog Last-Mile Crisis (McKinsey), and TelcoOne TowerCo Carve-out (Bain).
Unlock All 10 Cases in Simulation Suite →